We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions

By LabMedica International staff writers
Posted on 05 Oct 2026

Glioma brain tumors are highly infiltrative and can extend into nearby healthy brain tissue, making tumor margins difficult to define during surgery. More...

Residual tumor cells may contribute to recurrence and complicate subsequent treatment, while standard molecular methods generally provide results only after the procedure. To support faster intraoperative assessment, researchers have developed a mass spectrometry method that can evaluate resected brain tissue in about three minutes.

Purdue University (West Lafayette, IN, USA) researchers, working with Mayo Clinic (Rochester, MN, USA), developed a syringe touch spray approach for rapid molecular assessment of glioma tissue. The method uses ambient ionization mass spectrometry to analyze endogenous compounds from brain tissue in an open environment. In the workflow, fractions of samples taken during brain tumor surgery are transferred onto the plunger of a hypodermic needle, sprayed with a solution, and analyzed by tandem mass spectrometry.

The study used 86 human brain samples obtained through MRI-guided precision surgery. Researchers measured ratios of signals for multiple pairs of endogenous brain compounds. These metabolite ratios distinguished glioma from nontumor tissue with high confidence and also provided information on tumor subtype, grade, and mutation status.

The work was published in Proceedings of the National Academy of Sciences on September 30, 2026. The collaborating institutions were Purdue University and Mayo Clinic. The team reported that further evaluation would be needed during surgery, including a similar study involving more than 50 patients, before a clinical trial could be proposed.

“This technology would not replace the current standard of care during brain tumor surgery. Instead, it could provide surgeons with molecular information that is not currently available in the operating room, helping to guide surgical decisions during tumor removal, particularly at the tumor margins,” said R. Graham Cooks, Henry Bohn Hass Distinguished Professor of Chemistry at Purdue University.

Related Links
Purdue University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

Lung cancer is a leading cause of cancer-related death worldwide and is characterized by substantial cellular heterogeneity. Even within a single tumor, cancer cells can vary in aggressiveness, while immune,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.